The C-terminal tail of CHMP4C was recently shown [52] to be bound by the apoptosis inhibitor PDCD6IP, suggesting that the cancer-specific splice form of CHMP4C may have altered binding behavior with PDC6IP. Here, PDCD6IP is linked to cancer.